#lenacapavir — Public Fediverse posts

The HIV Breakthrough That Politics Couldn't Keep Up With

Like and share if you enjoyed this.

https://1ban.news/lenacapavir-rollout-bottlenecks/

#1ban #lenacapavir #rollout #bottlenecks #science #research

#HIV #lenacapavir

#HIV miracle drug begins rollout in earnest. #Lenacapavir is a twice-yearly drug offering near-complete protection against HIV. 🇳🇬 Nigeria just became the seventh African country to begin deliveries.

Nigeria: Lenacapavir - Hope Ri...

Why is #Gilead refusing to sell Lenacapavir to #MSF? Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most via @forbes https://www.forbes.com/sites/judystone/2026/04/16/breakthrough-hiv-drug-is-out-of-reach-for-many-who-need-it-most/

#Lenacapavir #ResearchEthics #bioethics

2/2

"We call on #Gilead to respond by April 13, 2026 clarifying:

1. Whether you will sell #lenacapavir directly to #MSF?
2. If not, why, given your stated production capacity?
3. If yes, at what price and how soon can delivery begin?

The #health of many people depends on your answers to these questions."

Via @sham |s faboulous newsletter what happened last week in Asia, Africa and the Americas.

1/2
"#Lenacapavir, a twice-yearly, long-acting #HIV prevention tool, represents one of the most promising advances towards ending #AIDS [.]. #Gilead has an obligation to ensure that access is not restricted by where people live, who they are, or what their country can pay. [.] this drug’s development was supported by public funding and through the trust of communities who participated in clinical trials, many of them in countries now excluded from affordable access [.]."

https://www.doctorswithoutborders.org/latest/prevention-should-not-be-privilege-msf-calls-gilead-direct-access-lenacapavir

Kenya and Zimbabwe are among the first African countries to offer #lenacapavir, a game-changing #HIV prevention injection that's shown 100% efficacy 💉. You only need it twice a year. Kenya is already giving it out free at public clinics 🇰🇪, while Zimbabwe is rolling it out across 24 sites 🇿🇼.

Kenya to offer patients free s...

#HIV #Lenacapavir

It looks like mutations have already created resistance to the common PrEP med, Lenacapavir, which was only approved a couple of years ago. That was fast.

https://www.poz.com/article/lenacapavir-resistance-may-impair-hiv-fitness?utm_source=POZ+Newsletters&utm_campaign=68563cbeb4-01-15-2026_POZ_News_THURSDAY_Update_MC&utm_medium=email&utm_term=0_d5ab18bd98-68563cbeb4-76763813

Ab 2027 soll das #HIV-Medikament
#lenacapavir in 120 Ländern mit niedrigem und mittlerem Einkommen 40 US-Dollar pro Patient*in und Jahr kosten. Weiterlesen im aktuellen Pharma-Brief: https://bukopharma.de/pharmabrief/pharma-brief-9-2025-spendenaufruf-theater-und-medikamente-in-der-umwelt/lenacapavir-wer-hat-zugang/

⚠️ 1.3 million people acquired HIV in 2024 alone, including thousands of adolescent girls and young women. WHO recommends twice-yearly injectable #lenacapavir as a new effective pre-exposure prophylaxis (PrEP) option to protect people at risk of HIV. Know more: bit.ly/47gS2eV

Gavin Newsom signs several pro-LGBTQ+ laws, vetoes gender-affirming care and HIV coverage

https://web.brid.gy/r/https://www.advocate.com/politics/gavin-newsom-lgbtq-bills-veto

Medizinischer Fortschritt mit Zugangshürden: #Lenacapavir könnte die #HIV-Prävention bereichern. Doch hohe Preise drohen das Potenzial zu begrenzen. Wer profitiert am Ende wirklich?
https://bukopharma.de/pharmabrief/pharma-brief-7-8-2025-lenacapavir-tabak-deals-und-geheimpreise/lenacapavir-zur-hiv-praevention/

Pharma-Brief 7-8 ist seit Kurzem online🎈 Unsere Themen: #Lenacapavir, #USA, #Tabak-Deals in Laos, Geheimpreise durch Lex Lilly, #mRNA-Technologie, Kürzungen in der Entwicklungshilfe und Nachrichten aus aller Welt 🌍
Hier geht es zur Ausgabe:
https://bukopharma.de/pharmabrief/pharma-brief-7-8-2025-lenacapavir-tabak-deals-und-geheimpreise/

#GoodNews: Die #USA halten ihr Versprechen: Der Durchbruch in der #HIV-Prävention, #Lenacapavir, wird finanziert! Das zweimal jährlich spritzbare Medikament könnte Millionen – besonders junge Frauen in Subsahara-Afrika – vor HIV schützen.

via: Fix The News

https://archive.md/8dKLZ

First 100% effective #HIV prevention drug is approved and going global
An 44 year epidemic might finally be quelled, with milestone approval of first HIV drug that offers 100% protection with its twice-yearly injections.
In the US, #FDA has approved the novel #lenacapavir – sold under the brand name #Yeztugo – a class of #drugs known as capsid inhibitors, which provide almost 100% protection against HIV infection, which currently affects 1.3 million people every year.
https://newatlas.com/infectious-diseases/hiv-prevention-fda-lenacapavir/